Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

Military

Published November 15, 2026 · Updated November 16, 2026

US Spends $4.9 Million On Ibogaine Trials for Veterans with PTSD - Military.com

Read the full story at Military

ibogaine to investigate its use in treating veterans with post-traumatic stress disorder (PTSD). Its supporters claim that ibogaine can treat.

Surfaced by 2 Google Alerts

  • Ibogaine
  • Psychedelics south america